Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 2
Development Phase
1
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
0 competitors in EGFR Mutant Advanced Non-small Cell Lung Cancer
View Full LandscapeTarget Indication
EGFR Mutant Advanced Non-small Cell Lung Cancer
Clinical Trial
NCT05394831Last updated: 1/29/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
Skin Structures and Soft Tissue Infections
Immunogenicity
Neovascular (Wet) Age-related Macular Degeneration
First-line Treatment of HER2-positive Recurrent or Metastatic Breast Cancer
Anemia